4.36
+0.14(+3.32%)
Currency In USD
| Previous Close | 4.22 |
| Open | 4.19 |
| Day High | 4.41 |
| Day Low | 4.15 |
| 52-Week High | 6.18 |
| 52-Week Low | 2.37 |
| Volume | 1.1M |
| Average Volume | 936,606 |
| Market Cap | 560.48M |
| PE | -8.38 |
| EPS | -0.52 |
| Moving Average 50 Days | 4.89 |
| Moving Average 200 Days | 4.19 |
| Change | 0.14 |
If you invested $1000 in Cytek Biosciences, Inc. (CTKB) since IPO date, it would be worth $232.41 as of March 09, 2026 at a share price of $4.36. Whereas If you bought $1000 worth of Cytek Biosciences, Inc. (CTKB) shares 3 years ago, it would be worth $464.82 as of March 09, 2026 at a share price of $4.36.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Cytek® Biosciences Celebrates One Year of Operations at Singapore Facility, Accelerating Growth and Regional Impact
GlobeNewswire Inc.
4 hours ago
Anniversary Milestone Highlights Expanded Manufacturing Capacity, Stronger Asia-Pacific Presence, and Measurable Contributions to Global Supply Chain Resilience Cytek Singapore facility Cytek Biosciences marks the one-year anniversary of its Singap
Cytek Biosciences to participate at the TD Cowen 46th Annual Health Care Conference
GlobeNewswire Inc.
Feb 18, 2026 9:05 PM GMT
FREMONT, Calif., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the company will be participating in the upcoming TD Cowen 46th Annual Health Care Conference in B
Cytek Biosciences to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026
GlobeNewswire Inc.
Feb 12, 2026 9:05 PM GMT
FREMONT, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), today announced it will report financial results for the fourth quarter and full year 2025 after market close on Thursday, F